Pure Global

Tachycardia as an Indication for Prophylactic Phenylephrine Injection in Caesarean Section Under Spinal Anesthesia; an Observational Study - Trial NCT06220942

Access comprehensive clinical trial information for NCT06220942 through Pure Global AI's free database. This phase not specified trial is sponsored by Ain Shams University and is currently Recruiting. The study focuses on Anesthesia. Target enrollment is 80 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06220942
Recruiting
drug
Trial Details
ClinicalTrials.gov โ€ข NCT06220942
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Tachycardia as an Indication for Prophylactic Phenylephrine Injection in Caesarean Section Under Spinal Anesthesia; an Observational Study

Study Focus

Anesthesia

Phenylephrine

Observational

drug

Sponsor & Location

Ain Shams University

Cairo, Egypt

Timeline & Enrollment

N/A

Oct 05, 2023

May 01, 2024

80 participants

Primary Outcome

Occurrence of Hypotension Avoidance of Hypotension Avoidance of Hypotension

Summary

The value of phenylephrine administration in response to tachycardia in preventing
 hypotension after spinal anesthesia in elective cesarean section.

ICD-10 Classifications

Anaesthetic, unspecified
Other and unspecified general anaesthetics
Local anaesthetics
Other complications of anaesthesia
Complication of anaesthesia during labour and delivery, unspecified

Data Source

ClinicalTrials.gov

NCT06220942

Non-Device Trial